• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Estimating treatment effect in a proportional hazards model in randomized clinical trials with all-or-nothing compliance.在具有全或无依从性的随机临床试验中,估计比例风险模型中的治疗效果。
Biometrics. 2016 Sep;72(3):742-50. doi: 10.1111/biom.12472. Epub 2016 Jan 22.
2
Semiparametric regression analysis of interval-censored data.区间删失数据的半参数回归分析
Biometrics. 2000 Dec;56(4):1139-44. doi: 10.1111/j.0006-341x.2000.01139.x.
3
Performance of statistical methods for analysing survival data in the presence of non-random compliance.存在非随机依从性时分析生存数据的统计方法的性能。
Stat Med. 2010 Dec 20;29(29):2994-3003. doi: 10.1002/sim.4070. Epub 2010 Oct 20.
4
A flexible, computationally efficient method for fitting the proportional hazards model to interval-censored data.一种将比例风险模型应用于区间删失数据的灵活且计算高效的方法。
Biometrics. 2016 Mar;72(1):222-31. doi: 10.1111/biom.12389. Epub 2015 Sep 22.
5
Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.随机试验中治疗不依从及后续无反应的似然方法。
Biometrics. 2005 Jun;61(2):325-34. doi: 10.1111/j.1541-0420.2005.040313.x.
6
Causal proportional hazards models and time-constant exposure in randomized clinical trials.随机临床试验中的因果比例风险模型与时间恒定暴露
Lifetime Data Anal. 2005 Dec;11(4):435-49. doi: 10.1007/s10985-005-5233-z.
7
A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.一种用于在具有全有或全无依从性的随机试验中实际接受治疗效果的因果比例风险估计器。
Biometrics. 2003 Mar;59(1):100-5. doi: 10.1111/1541-0420.00012.
8
A joint model for survival and longitudinal data measured with error.一种用于具有测量误差的生存数据和纵向数据的联合模型。
Biometrics. 1997 Mar;53(1):330-9.
9
Stochastic EM algorithm for doubly interval-censored data.双重区间删失数据的随机 EM 算法。
Biostatistics. 2013 Sep;14(4):766-78. doi: 10.1093/biostatistics/kxt019. Epub 2013 May 30.
10
A version of the EM algorithm for proportional hazard model with random effects.一种用于具有随机效应的比例风险模型的期望最大化(EM)算法版本。
Biom J. 2005 Dec;47(6):847-62. doi: 10.1002/bimj.200410141.

引用本文的文献

1
Estimation of causal quantile effects with a binary instrumental variable and censored data.使用二元工具变量和删失数据估计因果分位数效应
J R Stat Soc Series B Stat Methodol. 2021 Jul;83(3):559-578. doi: 10.1111/rssb.12431. Epub 2021 Jul 1.
2
Causal Proportional Hazards Estimation with a Binary Instrumental Variable.使用二元工具变量的因果比例风险估计
Stat Sin. 2021 Apr;31(2):673-699. doi: 10.5705/ss.202019.0096.
3
Instrumental variable estimation of complier causal treatment effect with interval-censored data.工具变量法估计区间截断数据下的遵从性因果处理效应。
Biometrics. 2023 Mar;79(1):253-263. doi: 10.1111/biom.13565. Epub 2021 Oct 12.
4
Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological Papers.统计方法在调整时间事件结局和卫生技术评估中患者不依从性对治疗效果估计的应用:方法学论文的系统评价。
Med Decis Making. 2019 Nov;39(8):910-925. doi: 10.1177/0272989X19881654. Epub 2019 Oct 24.

本文引用的文献

1
The hazards of hazard ratios.风险比的危害
Epidemiology. 2010 Jan;21(1):13-5. doi: 10.1097/EDE.0b013e3181c1ea43.
2
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.基因表达与化疗对淋巴结阴性、雌激素受体阳性乳腺癌女性患者的益处。
J Clin Oncol. 2006 Aug 10;24(23):3726-34. doi: 10.1200/JCO.2005.04.7985. Epub 2006 May 23.
3
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.一种用于预测他莫昔芬治疗的、淋巴结阴性乳腺癌复发的多基因检测方法。
N Engl J Med. 2004 Dec 30;351(27):2817-26. doi: 10.1056/NEJMoa041588. Epub 2004 Dec 10.
4
A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.一种用于在具有全有或全无依从性的随机试验中实际接受治疗效果的因果比例风险估计器。
Biometrics. 2003 Mar;59(1):100-5. doi: 10.1111/1541-0420.00012.
5
Principal stratification in causal inference.因果推断中的主分层
Biometrics. 2002 Mar;58(1):21-9. doi: 10.1111/j.0006-341x.2002.00021.x.
6
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study.高危淋巴结阴性乳腺癌辅助化疗的生存优势:十年分析——一项多组间研究
J Clin Oncol. 1998 Nov;16(11):3486-92. doi: 10.1200/JCO.1998.16.11.3486.
7
Covariance analysis of censored survival data.删失生存数据的协方差分析
Biometrics. 1974 Mar;30(1):89-99.

在具有全或无依从性的随机临床试验中,估计比例风险模型中的治疗效果。

Estimating treatment effect in a proportional hazards model in randomized clinical trials with all-or-nothing compliance.

作者信息

Li Shuli, Gray Robert J

机构信息

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, U.S.A..

出版信息

Biometrics. 2016 Sep;72(3):742-50. doi: 10.1111/biom.12472. Epub 2016 Jan 22.

DOI:10.1111/biom.12472
PMID:26799700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5113714/
Abstract

We consider methods for estimating the treatment effect and/or the covariate by treatment interaction effect in a randomized clinical trial under noncompliance with time-to-event outcome. As in Cuzick et al. (2007), assuming that the patient population consists of three (possibly latent) subgroups based on treatment preference: the ambivalent group, the insisters, and the refusers, we estimate the effects among the ambivalent group. The parameters have causal interpretations under standard assumptions. The article contains two main contributions. First, we propose a weighted per-protocol (Wtd PP) estimator through incorporating time-varying weights in a proportional hazards model. In the second part of the article, under the model considered in Cuzick et al. (2007), we propose an EM algorithm to maximize a full likelihood (FL) as well as the pseudo likelihood (PL) considered in Cuzick et al. (2007). The E step of the algorithm involves computing the conditional expectation of a linear function of the latent membership, and the main advantage of the EM algorithm is that the risk parameters can be updated by fitting a weighted Cox model using standard software and the baseline hazard can be updated using closed-form solutions. Simulations show that the EM algorithm is computationally much more efficient than directly maximizing the observed likelihood. The main advantage of the Wtd PP approach is that it is more robust to model misspecifications among the insisters and refusers since the outcome model does not impose distributional assumptions among these two groups.

摘要

我们考虑在存在不依从且有事件发生时间结局的随机临床试验中,估计治疗效果和/或治疗与协变量交互作用效果的方法。与库齐克等人(2007年)的研究一样,假设患者群体基于治疗偏好由三个(可能是潜在的)亚组组成:矛盾组、坚持组和拒绝组,我们估计矛盾组中的效果。在标准假设下,这些参数具有因果解释。本文有两个主要贡献。首先,我们通过在比例风险模型中纳入随时间变化的权重,提出了一种加权符合方案(Wtd PP)估计器。在本文的第二部分,在库齐克等人(2007年)所考虑的模型下,我们提出了一种期望最大化(EM)算法,以最大化完全似然(FL)以及库齐克等人(2007年)所考虑的拟似然(PL)。该算法的E步涉及计算潜在成员线性函数的条件期望,EM算法的主要优点是风险参数可以通过使用标准软件拟合加权Cox模型来更新,并且基线风险可以使用封闭形式的解来更新。模拟表明,EM算法在计算上比直接最大化观察到的似然要高效得多。Wtd PP方法的主要优点是,由于结局模型不对坚持组和拒绝组之间的分布做假设,所以它对这两组中的模型误设更具稳健性。